-
-
-
-
-
-
-
OPKO Health's ModeX begins phase 1 trial of COVID-19 prevention drug
-
-
-
-
-
-
-
OPKO's ModeX partners with Regeneron on multispecific antibodies
-
-
-
-
-
-
-
OPKO Health (OPK) Misses Q1 EPS by 1c
-
-
-
-
-
-
-
Labcorp (LH) Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Opko Health (OPK)
-
-
-
-
-
-
-
Opko Health (OPK) PT Lowered to $3 at Piper Sandler
408,184 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

